0.9945
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.0045
+0.45%
Today's range
0.9602 - 1.0200
ISIN
N/A
Source
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 Jan 2021 07:00:00 By Nasdaq GlobeNewswire